Fresenius Medical Care AG/ US3580291066 /
10/06/2024 22:10:00 | Chg. -0.24 | Volume | Bid01:26:58 | Ask01:26:58 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
21.09USD | -1.13% | 263,848 Turnover: 4.35 mill. |
20.64Bid Size: 100 | 22.26Ask Size: 100 | 12.29 bill.USD | - | - |
GlobeNewswire
10/06
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
GlobeNewswire
07/05
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
GlobeNewswire
24/04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/02
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velp...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire
24/08/2023
CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...
GlobeNewswire
29/03/2022
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
GlobeNewswire
14/03/2022
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire
01/03/2022
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results